Truijers M, Resch T, Van Den Berg J C, Blankensteijn J D, Lönn L
Department of Surgery, Rijnstate Hospital Arnhem, The Netherlands.
J Cardiovasc Surg (Torino). 2009 Aug;50(4):423-38.
Endovascular aneurysm repair (EVAR) represents one of the greatest advances in vascular surgery over the past 50 years. In contrast to conventional aneurysm repair, EVAR requires accurate preoperative imaging and stringent postoperative surveillance. Duplex ultrasound (DUS), transesophageal echocardiography, intravascular ultrasound, computed tomography (CT) and magnetic resonance (MR), each provide useful information for patient selection, choice of endograft type and surveillance. Today most interventionists and surgeons will rely on CT or MR to assess aortic morphology, evaluate access artery patency and locate side branch orifices. However, recent developments in cross-sectional imaging, including advanced image postprocessing, multi-modality image fusion and new contrast agents have resulted in improved spatial resolution for preoperative planning. Advanced reconstruction algorithms, like dynamic CTA and MRA, provide valuable information on dynamic changes in aneurysm morphology that might have an important impact on endograft selection. During follow-up, imaging of the graft and aneurysm is of utmost importance to identify patients in need of secondary intervention. This has led to rigorous follow-up protocols including duplex ultrasound and regular CT examinations. The use of these intense follow-up protocols has recently been questioned because of high radiation dose and the frequent use of nephrotoxic contrast agents. New imaging modalities like contrast enhanced DUS, dynamic MR and dual-source CT could reduce radiation dose and obviate the need for nephrotoxic contrast. Up-to-date knowledge of non-invasive vascular imaging and image processing is crucial for EVAR planning and is essential for the development of follow-up programs involving reduced risk of harmful side effects.
血管内动脉瘤修复术(EVAR)是过去50年来血管外科领域最重大的进展之一。与传统的动脉瘤修复术不同,EVAR需要准确的术前成像和严格的术后监测。双功超声(DUS)、经食管超声心动图、血管内超声、计算机断层扫描(CT)和磁共振成像(MR),每一种都能为患者选择、腔内移植物类型的选择和监测提供有用信息。如今,大多数介入医生和外科医生会依靠CT或MR来评估主动脉形态、评估入路动脉通畅情况以及定位侧支开口。然而,横断面成像的最新进展,包括先进的图像后处理、多模态图像融合和新型造影剂,已提高了术前规划的空间分辨率。先进的重建算法,如动态CT血管造影(CTA)和磁共振血管造影(MRA),可提供有关动脉瘤形态动态变化的有价值信息,这可能对腔内移植物的选择产生重要影响。在随访期间,对移植物和动脉瘤进行成像对于识别需要二次干预的患者至关重要。这导致了包括双功超声和定期CT检查在内的严格随访方案。由于高辐射剂量和肾毒性造影剂的频繁使用,最近这些密集随访方案的使用受到了质疑。新型成像模式,如对比增强DUS、动态MR和双源CT,可降低辐射剂量并避免使用肾毒性造影剂。掌握最新的无创血管成像和图像处理知识对于EVAR规划至关重要,对于制定涉及降低有害副作用风险的随访计划也必不可少。